about
MicroRNA dysregulation in diabetic ischemic heart failure patientsAn integrated approach for experimental target identification of hypoxia-induced miR-210Nitric oxide, oxidative stress, and p66Shc interplay in diabetic endothelial dysfunctionNoncoding RNA in age-related cardiovascular diseasesmiR-210: More than a silent player in hypoxiaDeregulated microRNAs in myotonic dystrophy type 2Na+/K+ATPase activity inhibition and isoform-specific translocation of protein kinase C following angiotensin II administration in isolated eel enterocytes.HypoxamiR regulation and function in ischemic cardiovascular diseases.Common micro-RNA signature in skeletal muscle damage and regeneration induced by Duchenne muscular dystrophy and acute ischemia.Genome wide identification of aberrant alternative splicing events in myotonic dystrophy type 2.Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing.Long noncoding RNA dysregulation in ischemic heart failure.Oxidative stress and microRNAs in vascular diseases.Epigenetic mechanisms of hyperglycemic memory.microRNAs in ischaemic cardiovascular diseases.MiR-216a: a link between endothelial dysfunction and autophagy.Effects of extracellular nucleotides in the thyroid: P2Y2 receptor-mediated ERK1/2 activation and c-Fos induction in PC Cl3 cells.Angiotensin II AT1 receptor stimulates Na+ -K+ATPase activity through a pathway involving PKC-zeta in rat thyroid cells.Angiotensin II stimulation of Na+/K+ATPase activity and cell growth by calcium-independent pathway in MCF-7 breast cancer cells.Increase of [Ca(2+)](i) via activation of ATP receptors in PC-Cl3 rat thyroid cell line.Muscarinic acetylcholine receptor activation induces Ca2+ mobilization and Na+/K+-ATPase activity inhibition in eel enterocytes.MicroRNAs in Hypoxia Response.Plasma microRNAs as biomarkers for myotonic dystrophy type 1.AT1 angiotensin II receptor mediates intracellular calcium mobilization in normal and cancerous breast cells in primary culture.Activation of P2Y2 purinoceptor inhibits the activity of the Na+/K+-ATPase in HeLa cells.Activation of P2Y2 receptor induces c-FOS protein through a pathway involving mitogen-activated protein kinases and phosphoinositide 3-kinases in HeLa cells.Angiotensin II activates extracellular signal regulated kinases via protein kinase C and epidermal growth factor receptor in breast cancer cells.PKC-zeta is required for angiotensin II-induced activation of ERK and synthesis of C-FOS in MCF-7 cells.Mitogenic signalling by B2 bradykinin receptor in epithelial breast cells.Co-expression of thymidine kinase and cathepsin D in 200 primary breast carcinomas.Dysregulation and cellular mislocalization of specific miRNAs in myotonic dystrophy type 1MicroRNA signatures in peripheral blood mononuclear cells of chronic heart failure patientsTranscriptionally active non-ligand binding oestrogen receptors in breast cancerRelation of cathepsin D level to the estrogen receptor in human breast cancerp53 associated with cathepsin D in primary breast cancerRelationships between tamoxifen binding proteins in primary breast cancer biopsiesBradykinin stimulates cell proliferation through an extracellular-regulated kinase 1 and 2-dependent mechanism in breast cancer cells in primary culture
P50
Q24618462-436469F3-158F-45DD-A18E-E21F2C900E95Q24646947-44C842A0-F533-4A11-AF17-5F56C4A8C1BEQ26830607-D4805C3B-A5FD-4D3C-8F68-6887DA7D44E2Q28081466-B1372079-DE1F-4CBB-A5F9-AE5D65B85C13Q28306244-1F8D4DBD-46A4-4F02-960D-73EDA1E321E2Q28727681-848A1E0C-F4C7-4EA6-8FCA-355FE5954922Q31971790-C631C91F-80B1-4DB6-B28D-C66B02BC2EF6Q34082010-6B2AE9EE-7DAC-4127-B713-FA93E694393DQ34986949-7FFD98E4-0538-4F2C-A29B-123C0FB36C43Q35145526-0F457EE7-7121-4D60-A0E4-0975CFADC06BQ36785271-772536B5-CA7E-4C0E-953A-9CD571236375Q37017986-C2725F7B-7C7A-471B-AD1E-F704BC6FD26AQ38131402-E6562603-2A76-45CB-B1F2-7F6F8A94360CQ38208510-F4B5F9E3-09B9-43BA-8FC6-E95CCAE5AD9FQ39323709-C35557E0-A505-4B78-B987-03D71AE1EC34Q40138320-98AD240A-B577-41ED-84C5-157B59A0B2DDQ40456341-49CDE857-7C6D-485E-AFAA-7CD4017BEA7FQ40677627-9026F172-D62F-42D3-937E-F7FDC84F41E7Q40732162-A20E90B0-269F-4720-9081-8D8FB44E8608Q40762657-D21A3E5A-0191-4141-AE0D-B08E9F605315Q42521371-72CC48A4-9FD7-40FF-B1F7-6EED9AA81D54Q42837550-76C1B267-9411-4B35-B8EC-44B867E839D3Q43489264-AB435145-680A-47C1-8BD7-EAC90A7A06A3Q44070694-19801C0F-78F3-412F-B3F0-243F9C2523FDQ44195101-D43F392A-DC95-48CB-AF27-472F8B56D08CQ44372844-4C62C976-1015-4BCA-AA8C-00EBB433FED5Q44481479-D9DF4B39-260E-4652-B8C5-7855FF41DA10Q44564561-AB6C852A-7595-41A1-B5B7-478FA18EB05CQ44998281-BA9374B9-562D-43CB-A3ED-F28F028E103EQ52070638-5C851427-B633-49B1-A4ED-A34C98752D97Q57085792-B3E4454C-F176-478D-B83F-1F3BF8BAADABQ61387983-6A576EA1-03E4-4244-97A2-BDAC13DE32ADQ67593134-9956FF2F-98E5-4EFF-A5C6-FAE7809F9A91Q68212237-5F76241A-A509-4AF9-8181-1E4BCB1EC169Q70779524-B3D1A67B-A8CF-4098-A48C-3C93AABABC9DQ72444184-ACFE15B1-6350-4160-A95F-061FF2B47871Q81002583-3C3897D6-AF72-4743-8E1C-F40856B5DAE1
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Simona Greco
@ast
Simona Greco
@en
Simona Greco
@es
Simona Greco
@nl
type
label
Simona Greco
@ast
Simona Greco
@en
Simona Greco
@es
Simona Greco
@nl
prefLabel
Simona Greco
@ast
Simona Greco
@en
Simona Greco
@es
Simona Greco
@nl
P106
P1153
35188911400
P21
P31
P496
0000-0002-0275-7221